SINGAPORE, July 6, 2023 /PRNewswire/ -- CytoMed Therapeutics Limited (NASDAQ: GDTC) ("CytoMed" or "Company"), a Singapore-based biopharmaceutical company focused on harnessing its proprietary ...
In a groundbreaking medical development, a Norwegian man has become the 10th person in the world cured of HIV after receiving a stem cell transplant from his brother. Learn how this breakthrough works ...
A study confirms a new case of long‑term remission following a stem cell transplant from a donor with a unique genetic mutation ...
Proprietary platform represents the first known approach capable of sustained γδ T cell expansion, eliminating target cells with robust potency INB-619, a next generation γδ TCE targeting CD19, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results